MedTrace Logo

Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults

NCT01422902 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-02-08

No results posted yet for this study

Summary

This study is a multi-site, double-blind, randomized, controlled clinical trial to assess the safety and effectiveness of plasticity-based, adaptive, computerized-based cognitive remediation treatment versus a computer-based control.

The investigators proposed that a computerized cognitive remediation program based upon the principles of brain plasticity may improve information processing and thus drive clinically significant improvements in cognitive and functional performance in individuals with schizophrenia.

Conditions

Interventions

OTHER

Plasticity-based Cognitive Training

OTHER

Non-plasticity-based Training

Computer games

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Posit Science Corporation

    lead INDUSTRY

Principal Investigators

  • Henry W. Mahncke, PhD · Posit Science Corporation

  • Richard Keefe, PhD · Schizophrenia Trials Network

  • Scott Stroup, MD, MPH · Schizophrenia Trials Network

  • Cate Stasio · Posit Science Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-03-31
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422902 on ClinicalTrials.gov